ArticleScientific reports2025
Enhancing lymphoma cancer detection using deep transfer learning on histopathological images.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Hierarchical vision transformers for Epstein-Barr virus status and histological subtype prediction in Hodgkin lymphoma whole-slide images.Journal of pathology informatics · 2026Article
- Automated leukemia detection from microscopic images using deep transfer learning with explainable AI-based analysis.Scientific reports · 2026Article
- Review
- Artificial intelligence in thyroid ultrasound: clinical applications and perspectives.Frontiers in endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lymphoma histopathological diagnosis is complex due to rare subtypes, morphological overlaps, and poor tumor differentiation. In this paper, an AI-based system using deep transfer learning and simulated federated learning is developed to classify two lymphoma types i.e. Chronic Lymphocytic Leukemia (CLL) and Follicular Lymphoma (FL) from a dataset of 4500 histopathological images. Six models (VGG-16, VGG-19, MobileNetV2, ResNet50, DenseNet161, and Inception V3) were evaluated across four data thresholds (0.05 to 0.2). These models used fine-tuned convolutional layers to automatically extract high-level image features relevant to tissue morphology; the extracted features were processed internally through each model's classifier, forming an end-to-end classification pipeline. DenseNet161 achieved the best classification performance across thresholds, while Inception V3 showed the highest accuracy (97.5%) and lowest RMSE (0.393) in the testing phase using deep learning. A simulated federated learning setup was also explored, where Inception V3 again outperformed other models, indicating its robustness in decentralized learning scenarios. The reported evaluation metrics loss, accuracy, precision, RMSE, F1 score, and recall, are derived from the testing phase, ensuring an accurate assessment of generalization performance. The findings highlight the efficacy of deep transfer learning in early and accurate lymphoma detection, with Inception V3 and DenseNet161 demonstrating strong performance across both learning paradigms. However, since federated learning was not fully deployed in a real-world distributed environment, its broader applicability remains a subject for future exploration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.